Gene Therapy for Inherited Genetic Disorders Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: GBD8C005FA22EN
Market Monitor Global

Abstracts

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.

This report contains market size and forecasts of Gene Therapy for Inherited Genetic Disorders in Global, including the following market information:

Global Gene Therapy for Inherited Genetic Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gene Therapy for Inherited Genetic Disorders market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Eye Disorders Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gene Therapy for Inherited Genetic Disorders include BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc and Spark Therapeutics Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy for Inherited Genetic Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Therapy for Inherited Genetic Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, by Type, 2021 (%)

• Eye Disorders
• Hematological Disorders
• Central Nervous System Disorders
• Muscular Disorders
• Others

Global Gene Therapy for Inherited Genetic Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research Institute
• Others

Global Gene Therapy for Inherited Genetic Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gene Therapy for Inherited Genetic Disorders Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gene Therapy for Inherited Genetic Disorders revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gene Therapy for Inherited Genetic Disorders revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioMarin Pharmaceutical Inc.
• bluebird bio Inc.
• Novartis AG
• Orchard Therapeutics Plc
• Spark Therapeutics Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Therapy for Inherited Genetic Disorders Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Therapy for Inherited Genetic Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE THERAPY FOR INHERITED GENETIC DISORDERS OVERALL MARKET SIZE

2.1 Global Gene Therapy for Inherited Genetic Disorders Market Size: 2021 VS 2028
2.2 Global Gene Therapy for Inherited Genetic Disorders Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Therapy for Inherited Genetic Disorders Players in Global Market
3.2 Top Global Gene Therapy for Inherited Genetic Disorders Companies Ranked by Revenue
3.3 Global Gene Therapy for Inherited Genetic Disorders Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy for Inherited Genetic Disorders Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gene Therapy for Inherited Genetic Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy for Inherited Genetic Disorders Players in Global Market
  3.6.1 List of Global Tier 1 Gene Therapy for Inherited Genetic Disorders Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy for Inherited Genetic Disorders Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gene Therapy for Inherited Genetic Disorders Market Size Markets, 2021 & 2028
  4.1.2 Eye Disorders
  4.1.3 Hematological Disorders
  4.1.4 Central Nervous System Disorders
  4.1.5 Muscular Disorders
  4.1.6 Others
4.2 By Type - Global Gene Therapy for Inherited Genetic Disorders Revenue & Forecasts
  4.2.1 By Type - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2022
  4.2.2 By Type - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2023-2028
  4.2.3 By Type - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Therapy for Inherited Genetic Disorders Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research Institute
  5.1.5 Others
5.2 By Application - Global Gene Therapy for Inherited Genetic Disorders Revenue & Forecasts
  5.2.1 By Application - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2022
  5.2.2 By Application - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2023-2028
  5.2.3 By Application - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gene Therapy for Inherited Genetic Disorders Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue & Forecasts
  6.2.1 By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2022
  6.2.2 By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue, 2023-2028
  6.2.3 By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028
  6.3.2 US Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.3.3 Canada Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.3.4 Mexico Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028
  6.4.2 Germany Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.3 France Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.4 U.K. Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.5 Italy Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.6 Russia Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.7 Nordic Countries Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.4.8 Benelux Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028
  6.5.2 China Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.5.3 Japan Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.5.4 South Korea Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.5.5 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.5.6 India Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028
  6.6.2 Brazil Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.6.3 Argentina Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028
  6.7.2 Turkey Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.7.3 Israel Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.7.4 Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028
  6.7.5 UAE Gene Therapy for Inherited Genetic Disorders Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BioMarin Pharmaceutical Inc.
  7.1.1 BioMarin Pharmaceutical Inc. Corporate Summary
  7.1.2 BioMarin Pharmaceutical Inc. Business Overview
  7.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Major Product Offerings
  7.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Global Market (2017-2022)
  7.1.5 BioMarin Pharmaceutical Inc. Key News
7.2 bluebird bio Inc.
  7.2.1 bluebird bio Inc. Corporate Summary
  7.2.2 bluebird bio Inc. Business Overview
  7.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Major Product Offerings
  7.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Global Market (2017-2022)
  7.2.5 bluebird bio Inc. Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Major Product Offerings
  7.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Orchard Therapeutics Plc
  7.4.1 Orchard Therapeutics Plc Corporate Summary
  7.4.2 Orchard Therapeutics Plc Business Overview
  7.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Major Product Offerings
  7.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue in Global Market (2017-2022)
  7.4.5 Orchard Therapeutics Plc Key News
7.5 Spark Therapeutics Inc.
  7.5.1 Spark Therapeutics Inc. Corporate Summary
  7.5.2 Spark Therapeutics Inc. Business Overview
  7.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Major Product Offerings
  7.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue in Global Market (2017-2022)
  7.5.5 Spark Therapeutics Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy for Inherited Genetic Disorders Market Opportunities & Trends in Global Market
Table 2. Gene Therapy for Inherited Genetic Disorders Market Drivers in Global Market
Table 3. Gene Therapy for Inherited Genetic Disorders Market Restraints in Global Market
Table 4. Key Players of Gene Therapy for Inherited Genetic Disorders in Global Market
Table 5. Top Gene Therapy for Inherited Genetic Disorders Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gene Therapy for Inherited Genetic Disorders Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gene Therapy for Inherited Genetic Disorders Product Type
Table 9. List of Global Tier 1 Gene Therapy for Inherited Genetic Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy for Inherited Genetic Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gene Therapy for Inherited Genetic Disorders Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gene Therapy for Inherited Genetic Disorders Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gene Therapy for Inherited Genetic Disorders Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gene Therapy for Inherited Genetic Disorders Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2023-2028
Table 30. BioMarin Pharmaceutical Inc. Corporate Summary
Table 31. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product Offerings
Table 32. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), (2017-2022)
Table 33. bluebird bio Inc. Corporate Summary
Table 34. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product Offerings
Table 35. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Gene Therapy for Inherited Genetic Disorders Product Offerings
Table 38. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), (2017-2022)
Table 39. Orchard Therapeutics Plc Corporate Summary
Table 40. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product Offerings
Table 41. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), (2017-2022)
Table 42. Spark Therapeutics Inc. Corporate Summary
Table 43. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product Offerings
Table 44. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy for Inherited Genetic Disorders Segment by Type in 2021
Figure 2. Gene Therapy for Inherited Genetic Disorders Segment by Application in 2021
Figure 3. Global Gene Therapy for Inherited Genetic Disorders Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapy for Inherited Genetic Disorders Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapy for Inherited Genetic Disorders Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy for Inherited Genetic Disorders Revenue in 2021
Figure 8. By Type - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 12. US Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 16. Germany Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 17. France Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 24. China Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 28. India Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 30. Brazil Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gene Therapy for Inherited Genetic Disorders Revenue Market Share, 2017-2028
Figure 33. Turkey Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gene Therapy for Inherited Genetic Disorders Revenue, (US$, Mn), 2017-2028
Figure 37. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)